Mark David Bonnen MD

Cancer Service Line Physician Executive

800 Washington StBoston, MA 02111

Dr. Bonnen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bonnen's full profile Already have an account?

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2000 - 2004
Baylor College of MedicineInternship, Internal Medicine, 1999 - 2000
McGovern Medical School at UTHealthClass of 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2025 - 2028
TX State Medical License 2004 - 2027
American Board of Radiology Radiation Oncology

Clinical Trials

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
ACTIVE_NOT_RECRUITING
PHASE3

Publications & Presentations

PubMed

Topical Esomeprazole for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer: Protocol for a Phase 2 Randomized Controlled Trial.
Aaron Cheng, Pavela Bambekova, Yohannes T Ghebre, Mark D Bonnen, Timothy Wagner
JMIR Research Protocols. 2026-11-02
Measure What Matters: Rethinking Surrogate Metrics of Success in Radiation Oncology.
Lohith Satish, Joshua Asper, Mark Bonnen, Richard Tuli, Travis Corwin
International Journal of Radiation Oncology, Biology, Physics. 2026-11-01
Pumping Up Dermatologic Drug Reformulation: A Review of How Proton Pump Inhibitors May Revolutionize Scleroderma Treatment.
Aaron Cheng, David G Cotter, Manisha Ahir, Mohammad A Khan, Mark D Bonnen
The Journal of Clinical and Aesthetic Dermatology. 2026-03-01

Press Mentions

Cancer Centers Hand Survivorship Reins to APPs as Volumes GrowJune 30th, 2026
Tufts University-Tufts Medicine Launch Joint Research EnterpriseDecember 10th, 2025
Mays Cancer Center Earns Gold Standard for Excellence in Radiation OncologyFebruary 26th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Helen Shih, MD
RadOncBoston, MA
Paul Busse, MD
RadOncBoston, MA
John Mignano, MD
RadOncBoston, MA
Seth Kaufman, MD
RadOncBoston, MA
Matthew Katz, MD
RadOncBoston, MA
David Mayhew, MD
RadOncBoston, MA
Sophia Kamran, MD
RadOncBoston, MA
Amardeep Grewal, MD
RadOncBoston, MA
Tru-Khang Dinh, MD
RadOncBoston, MA
Jonathan Paly, DO
RadOncBoston, MA

Doximity / States / Massachusetts / Boston / Mark Bonnen, MD

Dr. Mark Bonnen, Dr. Mark Bonnen, MD, Dr. M Bonnen, Dr. Mark David Bonnen